Free Trial

UiPath, Inc. $PATH Shares Purchased by Vanguard Group Inc.

UiPath logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Vanguard Group increased its stake in UiPath by 2.5% in Q4, owning 49,114,941 shares (a 9.18% stake) valued at about $804.99 million after buying 1,219,057 additional shares.
  • UiPath beat expectations in its latest quarter with EPS of $0.30 vs. $0.25 expected and revenue of $481.11 million vs. $464.81 million, a 13.4% year‑over‑year revenue increase and a 17.53% net margin.
  • Wall Street consensus is a Hold (3 Buy / 14 Hold / 1 Sell) with a $14.07 average target; the stock has a $5.61 billion market cap, PE of 20.59, and a 52‑week range of $9.28–$19.84.
  • Five stocks we like better than UiPath.

Vanguard Group Inc. lifted its holdings in UiPath, Inc. (NYSE:PATH - Free Report) by 2.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 49,114,941 shares of the company's stock after acquiring an additional 1,219,057 shares during the quarter. Vanguard Group Inc. owned 9.18% of UiPath worth $804,994,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of UiPath by 1.9% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 37,871 shares of the company's stock worth $621,000 after acquiring an additional 720 shares during the period. Green Alpha Advisors LLC increased its stake in shares of UiPath by 3.4% in the fourth quarter. Green Alpha Advisors LLC now owns 29,519 shares of the company's stock worth $484,000 after acquiring an additional 973 shares during the period. Covestor Ltd increased its stake in shares of UiPath by 17.7% in the third quarter. Covestor Ltd now owns 6,522 shares of the company's stock worth $87,000 after acquiring an additional 981 shares during the period. Wealthfront Advisers LLC increased its stake in shares of UiPath by 3.6% in the third quarter. Wealthfront Advisers LLC now owns 32,886 shares of the company's stock worth $440,000 after acquiring an additional 1,149 shares during the period. Finally, CoreCap Advisors LLC boosted its holdings in UiPath by 92.3% during the fourth quarter. CoreCap Advisors LLC now owns 2,579 shares of the company's stock worth $42,000 after buying an additional 1,238 shares in the last quarter. Institutional investors and hedge funds own 62.50% of the company's stock.

UiPath Stock Performance

Shares of NYSE PATH opened at $10.71 on Friday. The company's fifty day moving average price is $10.95 and its 200 day moving average price is $13.57. UiPath, Inc. has a 1 year low of $9.28 and a 1 year high of $19.84. The company has a market capitalization of $5.61 billion, a PE ratio of 20.59, a price-to-earnings-growth ratio of 1.75 and a beta of 0.91.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings data on Wednesday, March 11th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.05. The business had revenue of $481.11 million for the quarter, compared to the consensus estimate of $464.81 million. UiPath had a net margin of 17.53% and a return on equity of 5.69%. The company's revenue was up 13.4% compared to the same quarter last year. During the same period last year, the firm posted $0.26 earnings per share. On average, equities analysts expect that UiPath, Inc. will post 0.32 EPS for the current year.

Wall Street Analysts Forecast Growth

PATH has been the topic of a number of recent analyst reports. Royal Bank Of Canada set a $14.00 price target on shares of UiPath in a report on Wednesday, February 11th. Bank of America lowered their price target on shares of UiPath from $14.00 to $12.00 and set an "underperform" rating on the stock in a report on Thursday, March 12th. Barclays increased their price target on shares of UiPath from $16.00 to $18.00 and gave the stock an "equal weight" rating in a report on Monday, January 12th. TD Cowen lowered their price target on shares of UiPath from $16.00 to $13.00 and set a "hold" rating on the stock in a report on Thursday, March 12th. Finally, Wells Fargo & Company lowered their price target on shares of UiPath from $14.00 to $13.00 and set an "equal weight" rating on the stock in a report on Thursday, March 12th. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $14.07.

Read Our Latest Stock Analysis on UiPath

UiPath Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

See Also

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines